Page last updated: 2024-09-05

tolvaptan and Hyperkalemia

tolvaptan has been researched along with Hyperkalemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kim, S; Kurita, Y; Sato, N; Uno, S1
Butler, J; Campia, U; Chioncel, O; Gheorghiade, M; Khan, SS; Konstam, MA; Maggioni, AP; Nodari, S; Rossignol, P; Senni, M; Subacius, H; Swedberg, K; Vaduganathan, M; Zannad, F1
Lindner, U; Schäffler, A1
Kettritz, R; Luft, FC1

Reviews

1 review(s) available for tolvaptan and Hyperkalemia

ArticleYear
[Disorders of fluid and electrolyte balance].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:48

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance

2011

Trials

1 trial(s) available for tolvaptan and Hyperkalemia

ArticleYear
Efficacy and safety of intravenous OPC-61815 compared with oral tolvaptan in patients with congestive heart failure.
    ESC heart failure, 2022, Volume: 9, Issue:5

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Diuretics; Female; Heart Failure; Humans; Hyperkalemia; Male; Tolvaptan

2022

Other Studies

2 other study(ies) available for tolvaptan and Hyperkalemia

ArticleYear
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial).
    The American journal of cardiology, 2015, Mar-15, Volume: 115, Issue:6

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Clinical Trials as Topic; Creatinine; Female; Follow-Up Studies; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Inpatients; Kaplan-Meier Estimate; Life Expectancy; Male; Middle Aged; Potassium; Research Design; Risk Factors; Stroke Volume; Tolvaptan; Treatment Outcome

2015
[Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
    Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:5

    Topics: Aged; Benzazepines; Female; Humans; Hyperkalemia; Hyponatremia; Inappropriate ADH Syndrome; Long-Term Care; Male; Middle Aged; Prognosis; Saline Solution, Hypertonic; Sodium; Tolvaptan; Water Deprivation

2015